Novel increasing dose regimen of tolvaptan for autosomal dominant polycystic kidney disease in patient with low tolerability. - Nakatani S; Ishimura E; Machiba Y; Nakatani A; Fujimoto K; Uedono H; Okute Y; Tsuda A; Mori K; Emoto M; Inaba M (Nephrology (Carlton, Vic.), 2018)